1-2 of 2
Gail T. Bukofzer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

ABBV-184: A Novel Survivin-specific TCR/CD3 Bispecific T-cell Engager is Active against Both Solid Tumor and Hematologic Malignancies

Available to Purchase
Adam S. Chervin, Jennifer D. Stone, Iwona Konieczna, Kelly M. Calabrese, Ningyan Wang, Dipica Haribhai, Feng Dong, Michael K. White, Luis E. Rodriguez, Gail T. Bukofzer, Paul A. Ellis, Cormac Cosgrove, Claudie Hecquet, Jerry D. Clarin, Joann P. Palma, Edward B. Reilly
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2023) 22 (8): 903–912.
https://doi.org/10.1158/1535-7163.MCT-22-0770
Published: 01 August 2023
View articletitled, ABBV-184: A Novel Survivin-specific TCR/CD3 Bispecific T-cell Engager is Active against Both Solid Tumor and Hematologic Malignancies
Open the PDF for ABBV-184: A Novel Survivin-specific TCR/CD3 Bispecific T-cell Engager is Active against Both Solid Tumor and Hematologic Malignancies in another window
Includes: Supplementary data
Journal Articles

Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitor

Free
Daniel H. Albert, Paul Tapang, Terrance J. Magoc, Lori J. Pease, David R. Reuter, Ru-Qi Wei, Junling Li, Jun Guo, Peter F. Bousquet, Nayereh S. Ghoreishi-Haack, Baole Wang, Gail T. Bukofzer, Yi-Chun Wang, Jason A. Stavropoulos, Kresna Hartandi, Amanda L. Niquette, Nirupama Soni, Eric F. Johnson, J. Owen McCall, Jennifer J. Bouska, Yanping Luo, Cherrie K. Donawho, Yujia Dai, Patrick A. Marcotte, Keith B. Glaser, Michael R. Michaelides, Steven K. Davidsen
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2006) 5 (4): 995–1006.
https://doi.org/10.1158/1535-7163.MCT-05-0410
Published: 28 April 2006
View articletitled, Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitor
Open the PDF for Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitor in another window